×
戻る Agenda
Session 3 : AAV Gene Therapy - Now and Then
Session Chair(s)
Teruyo Arato, PhD
Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan
Maki Tanaka
General Manager, Project Management Department
Takara Bio Inc., Japan
Speaker(s)
Challenges and Expected Solutions for Gene Therapy Using AAV Vectors
Takashi Okada
The University of Tokyo, Japan
Director, Center for Gene and Cell Therapy, The institute of Medical Science
Kazusaku Kamiya, PhD
Juntendo University Faculty of Medicine, Japan
Associate Professor / Department of Otorhinolaryngology
The Current State and Issues of Manufacturing and Quality Analysis of AAV Vectors at Each Stage of Development
Susumu Uchiyama, PhD
Osaka University, Japan
Professor / Department of Biotechnology, Graduate School of Bioengineering
Development of Gene Therapy Products - In Gene Therapy Using AAV Vectors Nonclinical Assessments -
Yusuke Kagawa
Novartis Pharma K.K., Japan
Yasuhiro Kishioka, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of Cellular and Tissue-based Products